Amdocs Limited reported $4.53B of revenue over the trailing twelve months, −9.4% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $4.53B (to FY2025). Net income: $565M, trailing twelve months to FY2025. Free cash flow: $645M, trailing twelve months to FY2025. Operating margin: 16%, trailing twelve months to FY2025.

DOXAmdocs Limited

Technology

$62.73-23% 1Y

$62.73

$49.8752 weeks$84.19

Latest close: below its 200-day averageOct 23, 2026what changed →

DOX as reported

Amdocs Limited reported $4.53B of revenue over the trailing twelve months, −9.4% on the year before. 11 reported series are charted on this page, each one as filed.

$4.53B

Revenue, trailing twelve months · to FY2025 · −9.4% against the twelve months before

Net income: $565M
Net income · +14% year on year · trailing twelve months to FY2025
Free cash flow: $645M
Free cash flow · +4.2% year on year · trailing twelve months to FY2025
Operating margin: 16%
Operating margin · trailing twelve months to FY2025

Details›

Every series Ryufin has for DOX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$4.53B	−9.4%	FY2025
Net income	$565M	+14%	FY2025
EPS	$5.05	+19%	FY2025
Gross margin	38%	n/a	FY2025
Operating margin	16%	n/a	FY2025
Net margin	12%	n/a	FY2025
ROE	16%	n/a	FY2025
ROA	9.0%	n/a	FY2025
ROIC	15%	n/a	FY2025
Free cash flow	$645M	+4.2%	FY2025
P/E	12.4	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.